|
2014
|
Invention
|
Solid state forms of cabazitaxel and processes for preparation thereof.
The invention relates to... |
|
2013
|
Invention
|
Solid state forms of cabazitaxel and processes for preparation thereof. The invention relates to ... |
|
2012
|
Invention
|
Processes and intermediates for preparing pralatrexate. Processes for preparing and purifying Pra... |
|
2011
|
Invention
|
Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for prepar... |
|
|
Invention
|
Solid state forms of ixabepilone. Crystalline forms of Ixabepilone are described in the present a... |
|
2010
|
Invention
|
Process for the preparation of n-protected-decylaminoethanal. Compounds useful in the preparation... |
|
|
Invention
|
Polymorphs of bendamustine hcl and processes for preparation thereof. Novel polymorphs of Bendamu... |
|
|
Invention
|
Polymorphs of fluticasone furoate and processes for preparation thereof. The present invention pr... |
|
2009
|
Invention
|
Polymorphs of vorinostat and vorinostat potassium salt and process for preparation thereof. Cryst... |
|
|
Invention
|
Polymorphs of fluticasone furoate and process for preparation thereof. Provided are polymorphs of... |
|
|
Invention
|
Crystalline forms of erlotinib base and erlotinib hcl. The preparation of crystalline Erlotinib b... |
|
|
Invention
|
Salts of (r)-5-(2-phenylsulphonylethenyl)-3-(n- methylpyrrolidin-2-ylmethyl)-1h-indole, 5-bromo-3... |
|
|
Invention
|
Method of manufacturing of 7-ethyl-10-hydroxycamptothecin. The method of manufacturing of 7-ethyl... |
|
|
Invention
|
Process for the preparation of capecitabine. The present application relates to an improved proce... |
|
2008
|
Invention
|
Process for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib hc... |
|
|
Invention
|
Processes for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib ... |
|
|
Invention
|
Stable formulations of crystalline erlotinib hcl. The present invention provides stable formulati... |
|
|
Invention
|
Crystalline forms of erlotinib hcl and formulations thereof. The invention provides a novel cryst... |
|
|
Invention
|
Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional f... |
|
|
Invention
|
Process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole.
The invention en... |
|
|
Invention
|
A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole. The invention e... |
|
|
Invention
|
Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydr... |
|
2004
|
Invention
|
Method of manufacturing of 7-ethyl-10-[4-(1-piperidino)-1- piperidino]- carbonyloxy- camptothecin... |
|
2001
|
Invention
|
A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities. A p... |
|
2000
|
Invention
|
Hmg-coa reductase inhibitor preparation process. The invention provides a simple and selective me... |
|
1999
|
Invention
|
Nitrogen feed in statin fermentation. A fermentation process is disclosed for producing an HMG-Co... |
|
1997
|
Invention
|
Selective process for the deacylation of acylated compounds. The invention provides a simple and... |
|
1996
|
Invention
|
Selective process for the deacylation of acylated compounds. The invention provides a simple and ... |
